|
![]() |
|||
|
||||
OverviewThe Stem Cell Ophthalmology Treatment Study, SCOTS, is the largest Institutional Review Board (IRB) approved ophthalmology study registered with the NIH (www.ClinicalTrials.gov Identifier NCT01920867). Jeffrey Weiss, M.D. is the Principal Investigator and Steven Levy M.D. is the Study Director. Discoveries made during SCOTS lead to the development of the Neurologic Stem Cell Treatment Study, NEST. NEST is IRB approved and registered with NIH (www.ClinicalTrials.gov Identifier NCT02795052). Full Product DetailsAuthor: Steven Levy MD , Jeffrey Neill Weiss MDPublisher: Createspace Independent Publishing Platform Imprint: Createspace Independent Publishing Platform Dimensions: Width: 21.60cm , Height: 0.20cm , Length: 28.00cm Weight: 0.118kg ISBN: 9781536934878ISBN 10: 1536934879 Pages: 40 Publication Date: 11 August 2016 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationJeffrey N. Weiss, M.D., is a retinal specialist practicing in Margate, Florida. He is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty member of Harvard Medical School and Visiting Scientist at M.I.T. Dr. Weiss is the President of Retina Associates of South Florida and is the Principal Investigator of SCOTS. Dr. Steven Levy is the President of MD Stem Cells and is the Study Director of SCOTS. Tab Content 6Author Website:Countries AvailableAll regions |